AAAAAA
Results:
1-15
|
Results: 15
Authors:
du Bois, A
Luck, HJ
Pfisterer, J
Schroeder, W
Blohmer, JU
Kimmig, R
Moebus, V
Quaas, J
Citation: A. Du Bois et al., Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer - a dose-finding study by the Arbeitsgemeinschaft Gynakologische Onkologie (AGO) Ovarian Cancer Study Group, ANN ONCOL, 12(8), 2001, pp. 1115-1120
Authors:
von Minckwitz, G
Costa, SD
Raab, G
Blohmer, JU
Eidtmann, H
Hilfrich, J
Merkle, E
Jackisch, C
Gademann, G
Tulusan, AH
Eiermann, W
Graf, E
Kaufmann, M
Citation: G. Von Minckwitz et al., Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: A randomized, controlled, open phase IIb study, J CL ONCOL, 19(15), 2001, pp. 3506-3515
Authors:
Sezer, O
Langelotz, C
Blohmer, JU
Schmid, P
Akrivakis, K
Possinger, K
Citation: O. Sezer et al., Detection of HMGI-C in the peripheral blood of breast cancer patients, EUR J CANC, 36(15), 2000, pp. 1944-1948
Authors:
Blohmer, JU
Citation: Ju. Blohmer, Irinotecan - a new option in the treatment of gynecological malignancies, ONKOLOGIE, 23, 2000, pp. 13-15
Authors:
Blohmer, JU
Lichtenegger, W
Citation: Ju. Blohmer et W. Lichtenegger, Treatment of gynecological carcinomas with Campto((R)), ONKOLOGIE, 23, 2000, pp. S37-S38
Authors:
Paepke, S
Schubert, R
Huttner, C
Blohmer, JU
Lichtenegger, W
Citation: S. Paepke et al., Breast cancer awareness and screening behavior: A cross sectional analysisof 2110 women, GEBURTSH FR, 60(12), 2000, pp. 620-624
Authors:
Sezer, O
Jugovic, D
Blohmer, JU
Turzynski, A
Thiel, G
Langelotz, C
Possinger, K
Kovar, H
Citation: O. Sezer et al., CD99 positivity and EWS-FLI1 gene rearrangement identify a breast tumor ina 60-year-old patient with attributes of the Ewing family of neoplasms, DIAGN MOL P, 8(3), 1999, pp. 120-124
Authors:
Blohmer, JU
Oellinger, H
Schmidt, C
Hufnagl, P
Felix, R
Lichtenegger, W
Citation: Ju. Blohmer et al., Comparison of various imaging methods with particular evaluation of Color Doppler sonography for planning surgery for breast tumors, ARCH GYN OB, 262(3-4), 1999, pp. 159-171
Authors:
von Minckwitz, G
Costa, SD
Eiermonn, W
Blohmer, JU
Tuluson, AH
Jackisch, C
Kaufmann, M
Citation: G. Von Minckwitz et al., Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel, J CL ONCOL, 17(7), 1999, pp. 1999-2005
Authors:
Blohmer, JU
Oellinger, H
Grineisen, Y
Paepke, S
Siewert, C
Siebert, G
Felix, R
Lichtenegger, W
Citation: Ju. Blohmer et al., Changes in spectral Doppler measurement of V-max after administration of an ultrasound contrast agent - A possible new variable for the differential diagnosis of breast lesions, TUMORDIAGN, 20(6), 1999, pp. 164-170
Authors:
Blohmer, JU
Citation: Ju. Blohmer, Screening and treatment of early cervical cancer, ONKOLOGIE, 22, 1999, pp. 25-26
Authors:
Costa, SD
von Minckwitz, G
Raab, G
Blohmer, JU
Dresel, V
Eidtmann, H
Hilfrich, J
Jackisch, C
Merkle, E
Gademann, G
Kaufmann, M
Citation: Sd. Costa et al., The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer, SEMIN ONCOL, 26(3), 1999, pp. 24-31
Authors:
Blohmer, JU
Huttner, C
Lichtenegger, W
Citation: Ju. Blohmer et al., Quality assurance for operations in nonpalpable breast lesions, GEBURTSH FR, 59(2), 1999, pp. M21-M24
Authors:
Blohmer, JU
Schmalisch, G
Klette, I
Grineisen, Y
Kohls, A
Guski, H
Lichtenegger, W
Citation: Ju. Blohmer et al., Increased incidence of cervical intraepithelial neoplasia in young women in the Mitte district, Berlin, Germany, ACT CYTOL, 43(2), 1999, pp. 195-200
Authors:
Oellinger, H
Blohmer, JU
Siewert, C
Hadijuana, J
Gutberlet, M
Ehrenstein, T
Lichtenegger, W
Felix, R
Citation: H. Oellinger et al., The optimal use of MR-Mammography (MRM) under consideration of economical aspects, ZBL CHIR, 123, 1998, pp. 42-46
Risultati:
1-15
|